M. tuberculosis molecular variation in CNS infection: evidence for strain-dependent neurovirulence

Neurology
Z ArvanitakisC Power

Abstract

To determine the molecular diversity among Mycobacterium tuberculosis isolates associated with central nervous system tuberculosis (CNS TB) in a defined cohort of HIV uninfected patients. A retrospective analysis was performed of clinical and laboratory data for all patients with CNS TB diagnosed in Manitoba, Canada, between 1979 and 1996. Restriction fragment-length polymorphisms (RFLP) of archival isolates of M. tuberculosis from CNS TB patients were determined and interpreted against the frequency of different isolates from all TB patients in the years 1992 to 1996. Among 2,334 patients with active TB, CNS TB was diagnosed in 42 (1.8%); meningitis with or without tuberculoma in 76%; and tuberculoma alone in 24%. CNS TB patients were significantly more likely to be young (<40 years old), female, and of Aboriginal origin. Morbidity (fixed/recurrent CNS deficit) rate was 29% and mortality rate was 26%. An adverse outcome, either morbidity or mortality, was significantly more common in those with meningitis. RFLP analysis of isolates (n=19) from CNS TB patients revealed 13 distinct restriction patterns with a predominance of the type 1 pattern (n=6). The frequency of type 1 restriction pattern was significantly greater in patien...Continue Reading

Citations

Sep 24, 1999·The Pediatric Infectious Disease Journal·T PillayA W Sturm
Feb 16, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·G ThwaitesJ Farrar
Nov 26, 2013·Human Immunology·Seema D ShekhawatRajpal S Kashyap
Aug 21, 2008·The Journal of Infectious Diseases·Linda A LarcombePeter W Nickerson
Apr 28, 2009·Current Anthropology·A K WilburJ E Buikstra
Jul 8, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·N E AndersonM G Thomas
Jun 6, 2009·Tuberculosis·Jutaporn YorsangsukkamolNaraporn Prayoonwiwat
Apr 26, 2013·Neurologia Medico-chirurgica·Yoshihisa MatsumotoKiyoshi Kazekawa
Jun 5, 2015·Frontiers in Cellular Neuroscience·Jonathan Paul SpanosMuazzam Jacobs
Sep 19, 2018·Clinical Neuroradiology·Martin Alexander SchallerStefan Weidauer
May 20, 2006·Revue neurologique·O SteichenT De Broucker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.